Company Overview
About InpharmD
InpharmD is an Atlanta-based healthcare technology company providing AI-assisted drug information and clinical pharmacist intelligence to healthcare providers — enabling physicians, nurses, and clinical staff to get evidence-based answers to complex drug questions (drug interactions, off-label use guidance, dosing in special populations, emerging therapies) through an AI platform that combines clinical pharmacist review with database-backed pharmaceutical intelligence. Founded in 2018 and a Y Combinator W21 graduate, InpharmD raised $6.63 million total including a $6.5 million seed round in December 2023 led by 645 Ventures with participation from Qlarant Capital and Atlanta Ventures.
Business Model & Competitive Advantage
InpharmD's platform delivers AI-generated drug information responses that are reviewed and validated by clinical pharmacists before delivery, providing a higher standard of reliability than pure AI-generated responses for clinical decision support. Healthcare providers can query drug interactions for complex polypharmacy patients, dosing guidance for renal or hepatic impairment, and evidence reviews for emerging treatments where prescribing guidance is evolving rapidly. The pharmacist-in-the-loop review model addresses the reliability requirements for clinical AI tools where incorrect information can cause patient harm.
Competitive Landscape 2025–2026
In 2025, InpharmD competes in the clinical decision support and pharmacy intelligence market with Wolters Kluwer (UpToDate, the dominant clinical reference), Elsevier (Clinical Pharmacology), IBM Watson Health (legacy), and newer AI clinical assistants (Doximity AI, Glass Health) for healthcare provider drug information. Clinical pharmacist access is increasingly limited in many hospital systems — telepharmacy and centralized pharmacy models have reduced the availability of pharmacists for individual clinician questions. InpharmD's AI-assisted pharmacist service expands access to pharmaceutical expertise. The 645 Ventures and YC backing validates the healthcare AI market opportunity. The 2025 strategy focuses on hospital system and health system enterprise deployments, expanding the AI model's pharmaceutical knowledge base, and building the formulary and insurance coverage intelligence that completes the prescribing decision context.
Recent Activity
View all →Key Differentiators
Emerging Innovator
InpharmD is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Compare InpharmD with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from InpharmD? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim InpharmD Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention InpharmD vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →